Credit Suisse knowingly helped structure over $2 billion in loans to Mozambican government entities while its own bankers pocketed $50 million in secret kickbacks from the contractor. The bank sold investment securities to global investors using offering documents it knew were false, concealing both the kickback payments and the risk that loan proceeds were being diverted to bribes. When the project began to fail, Credit Suisse engineered a bond exchange that benefited itself while further deceiving investors. Every step of this scheme was motivated by the bank’s desire to generate fees and protect its own financial exposure, at the expense of Mozambique’s population and investors worldwide.

This is a federal criminal charge filed by the U.S. Department of Justice, backed by extensive documentary evidence including internal emails, due diligence reports, recorded phone calls, and financial transaction records. The evidence is extraordinarily specific: it names the amounts paid, the people who received them, and the dates on which key decisions were made. The bank’s own internal communications describe the corruption, the valuation shortfalls, and the conscious decision to proceed regardless. This is not an overreach. This is one of the most thoroughly documented corporate corruption cases in recent banking history.

Mozambique is one of the poorest countries on earth. The fraud loaded over $2 billion in government-guaranteed debt onto the country’s books, much of it hidden from the IMF and international creditors. When the debt was revealed in 2016, the IMF suspended aid to Mozambique, cutting off critical financial support the government depended on for basic public services. The country’s credit rating collapsed from B to CCC, blocking access to international capital at reasonable rates. The government subsequently defaulted on its Eurobond obligations. This is not an abstract financial harm: it translates directly into reduced funding for schools, hospitals, infrastructure, and social programs in one of the world’s most vulnerable economies. A Swiss bank’s corruption extracted billions from a nation of 32 million people who had no voice in these transactions.

The evidence is damning. Credit Suisse’s own due diligence firm submitted a detailed report in March 2013 describing the Privinvest co-conspirator as a “master of kickbacks” involved in “corrupt practices.” The bank’s own senior executives had previously designated him an “undesirable client” and a senior executive had explicitly said “no” to working with him and Mozambique together. The bank’s compliance, reputational risk, anti-money laundering, and investment banking committees all reviewed the situation and approved the transactions regardless. Internally, employees raised concerns about corruption allegations in the press and asked whether an anti-money laundering review had ever been conducted. The answer was effectively no. Credit Suisse did not stumble into this. It chose to proceed because the fees were substantial and the kickbacks kept the right people quiet.

Investors worldwide bought EMATUM loan participation notes in good faith based on offering circulars that Credit Suisse knew were false. Those documents said proceeds would fund a legitimate tuna fishing project; in reality, hundreds of millions were diverted to bribes and kickbacks. When the fraud was revealed, EMATUM Security prices dropped sharply. Investors who agreed to the 2016 bond exchange, based on additional false disclosures, were further harmed when Mozambique subsequently defaulted on the Eurobonds they received in exchange. The bondholders were deceived twice, at both the original issuance and the restructuring, and suffered real financial losses as a result of Credit Suisse’s knowing misrepresentations.

A senior Credit Suisse executive made the motivation explicit in internal communications: the bank feared that if a competitor led the restructuring, it would be “positioned poorly” and give “firepower to the opposition to say another bank has been brought in to clean up the trade.” In other words, Credit Suisse continued managing a corrupt transaction it helped create in order to control the narrative and protect its own reputation and financial position. The bank also had a direct financial conflict of interest: by extending the EMATUM loan repayment date, it ensured it would be repaid first on its own ProIndicus loan investment, ahead of EMATUM investors. Investor protection never entered the calculus.

Credit Suisse is not an isolated case. The Mozambique scandal is part of a well-documented pattern in which large global banks facilitate corruption in developing nations where oversight is weaker and officials are more vulnerable to bribery. The bank’s internal systems, meant to catch exactly this kind of conduct, were either overridden or rationalized away at every step. This is the system working as designed for the powerful: compliance departments exist to manage legal exposure, not to stop profitable misconduct. When the fees are large enough and the victims are far away, banks make the calculation that the risk is worth taking. Stronger international anti-bribery enforcement, whistleblower protections, and genuine executive accountability (not just corporate fines) are the only way to change that calculus.

There are concrete actions you can take. Advocate for stronger enforcement of the Foreign Corrupt Practices Act and the U.K. Bribery Act, including criminal prosecution of individual executives, not just corporate-level fines. Support organizations that defend economic justice in developing nations, including Jubilee Debt Campaign and the Mozambique Debt Group, which have been fighting for debt cancellation and accountability. Demand that your pension funds and investment managers adopt strict anti-corruption investment criteria. Contact your elected representatives and call for mandatory beneficial ownership transparency for all corporate entities involved in cross-border finance. Share this story. When banks know their conduct will face sustained public scrutiny in addition to regulatory risk, the cost-benefit calculation shifts. Silence is how they get away with it.